Toxic milk (tx) is a copper disorder of mice that causes a hepatic accumulation of copper similar to that seen in patients with Wilson disease. Both disorders are caused by a defect in the ATP7B copper-transporting ATPase. A feature of the tx phenotype is the production of copper-deficient milk by lactating dams homozygous for the tx mutation ; the milk is lethal to the pups. It has not been determined whether the production of copperdeficient milk is a direct consequence of impaired expression of ATP7B protein in the mammary gland. With the use of immunohistochemistry, our study demonstrated that the ATP7B protein was mislocalized in the lactating tx mouse mammary gland, which would explain the inability of the tx mouse to secrete normal amounts of copper in milk. Confocal microscopy analysis showed that, in the lactating tx mammary gland, ATP7B was predominantly perinuclear in comparison with the diffuse, cyto-
INTRODUCTION
Wilson disease is an autosomal recessive defect of copper transport that results in hepatic cirrhosis and neurological disorders. The Wilson gene encodes a transmembrane copperbinding ATPase (ATP7B) that is expressed primarily in the liver and to a smaller extent in the heart, kidney, brain, skeletal muscle and lung [1, 2] . Mutations in the ATP7B gene lead to impaired biliary excretion of copper from the liver, resulting in excessive accumulation of copper in the liver that can cause liver failure or neurological problems owing to the deposition of excess copper released from the liver [3] .
Toxic milk (tx) is an autosomal recessive copper disorder of mice that causes the hepatic accumulation of copper similar to that seen in patients with Wilson disease [4] . The tx mouse has a single nucleotide change in the ATP7B gene from the normal (DL) mouse ; this results in the alteration of a highly conserved methionine residue to valine in the eighth transmembrane domain of the predicted protein [5] . In tx mice, liver copper levels were 14-fold higher than in DL mice 7 weeks after birth [4] and 55-fold higher in adult tx mice compared with adult control mice [6] .
An unusual feature of the tx disorder is the production of copper-deficient milk by lactating dams homozygous for the tx mutation [4] . Pups feeding from mutant dams often die as a result of the decreased copper levels in the milk. It is not known whether the production of copper-deficient milk is a direct consequence of impaired expression of the Wilson disease gene in the mammary gland, which decreases the transfer of copper into milk, or whether it is a secondary consequence of the inappropriate hepatic metabolism of copper. Decreased copper Abbreviation used : tx, toxic milk. 1 To whom correspondence should be addressed (e-mail leigha!deakin.edu.au).
plasmic localization of ATP7B in the lactating normal mammary gland. Lactating tx mice showed impaired delivery of copper from the mammary gland to the milk and this was not ameliorated by dietary copper supplementation. In contrast, the normal mouse mammary gland responded to increased dietary copper by increasing the amount of copper in milk. A change in the distribution of the ATP7B protein from perinuclear in the non-lactating gland to a diffuse, cytoplasmic localization in the lactating gland of the normal (DL) mouse suggests that the relocalization of APT7B is a physiological process that accompanies lactation. We conclude that the impaired copper transport from the mammary gland into milk in lactating tx mice is related to the mislocalization of ATP7B.
Key words : homoeostasis, lactation, subcellular distribution. levels in milk from patients with Wilson disease have not been reported.
A significant function for ATP7B protein in the transport of copper into milk in the mammary gland is suggested from studies in ATP7B-null mice, which were generated by using homologous recombination to disrupt the normal ATP7B gene. The copper concentrations in the mammary gland of lactating ATP7B-null mice were twice those in the mammary glands of control mice [7] . This result suggests that the copper uptake pathway in the mammary gland might be functional but that the secretory pathway is impaired.
In tx mice, the abnormal accumulation of copper in the liver is not due to decreased levels of expression of ATP7B mRNA, because a Northern blot analysis showed no difference between control and tx liver mRNA [5] . However, it is likely that the defect in copper transport results from an inactive mutant ATP7B protein. In cultured cells and normal rat hepatocytes, the ATP7B protein is located in the trans-Golgi network, but in response to elevated copper concentrations ATP7B relocates to a vesicular compartment within the cell [8, 9] . A form of ATP7B with the common disease-causing H1069Q mutation did not relocate in response to copper [10] . A similar effect of disease-causing mutations in blocking copper-induced trafficking has been reported for the closely related Menkes protein, ATP7A [11] .
Here we investigate the expression of the Wilson protein in the mammary gland of normal and tx mice. We find that the ATP7B protein is expressed at quite high levels in the mammary gland and, interestingly, lactation induces a dispersal similar to that seen in cultured cells exposed to high levels of copper. Signifi-cantly, the tx ATP7B did not show lactation-induced dispersal. Thus our results suggest that ATP7B is important in the delivery of copper into milk, and that trafficking of the protein from the trans-Golgi network to a vesicular compartment is part of this process.
MATERIALS AND METHODS

Animals
The tx mutation arose in the inbred DL strain and has subsequently been maintained on this background [4] . Toxic-milk pups are routinely fostered to normal mice because they have a very high mortality if allowed to remain suckling with their own mothers for more than 5 days. In the present study, tx pups were fostered to normal dams within 3 days. Fostering is considered essential for tx pup survival because the paradoxically low copper in tx dam milk and a presumed defect in the placental transfer of copper results in a copper-deficient state in the tx neonatal period. Normal pups (DL) were fostered within 40 h of birth to either normal or tx dams. Females carried and delivered between one and three litters and were culled while still lactating when pups were 5 days old. To investigate the effects of dietary copper supplementation, lactating dams were provided with water containing 0.1 mg\ml copper as copper acetate from the time of mating. The mice tolerated this level of copper with no obvious ill effects over a period of 3-4 months. The transport of copper from the mammary gland of the mother to the pups was estimated by measuring the copper content of the pup stomach. The analysis of stomach contents of pups has previously been used as an indicator of milk copper and zinc concentrations [4, 12] .
Mouse tissue
Mammary and liver tissue from non-lactating and lactating DL and tx mice was excised, frozen immediately and stored at k80 mC until use.
Atomic absorption spectrometry
Tissue was dried at 50 mC for 1 week, weighed and transferred into an acid-washed container to which 0.5 ml of nitric acid had been added. The samples were incubated at room temperature for 1 h, then at 65 mC for 4 h ; after this, 2.5 ml of deionized water was added, the samples were centrifuged and the supernatant was analysed with a Varian SpectraAA-880, with direct aspiration.
Preparation of ATP7B antibody
A polyclonal antibody against the mouse ATP7B protein was prepared after the immunization of rabbits with a fusion protein that spanned the copper-binding sites 2, 3 and 4. After precipitation with sodium sulphate, the IgG fraction was affinitypurified by affinity chromatography over the antigen linked to Sepharose 4B (M. Theophilos and J. F. B. Mercer, unpublished work).
Western-blot analysis
Mammary tissue (100 mg) was homogenized in 1.5 ml of 250 mM sucrose\10 mM Hepes (pH 7.5)\2.5 mM EDTA containing protease inhibitors used in accordance with the manufacturer's instructions (Boehringer Mannheim catalogue no. 1836170) and centrifuged for 1 min at 1000 g. The supernatant was centrifuged at 100 000 g for 60 min at 4 mC and the pellet was resuspended in 62.5 mM Tris\HCl (pH 7.5)\2.5 mM EDTA containing protease inhibitors. The extract (60 µg of protein) was fractionated by SDS\PAGE [7. 5 % (w\v) polyacrylamide] with a Bio-Rad Mini Protean Gel system. Proteins were transferred to nitrocellulose membranes at 4 mA\cm# for 120 min with a Bio-Rad Mini Trans-Blot in 25 mM Tris\HCl (pH 8.3)\192 mM glycine. After being blocked with 1 % (w\v) casein in TBST [0.05 M Tris\ HCl\0.15 M NaCl\0.1 % (v\v) Tween 20], the membrane was exposed to the ATP7B primary antibody (dilution 1 : 500) in blocking buffer for 2 h, then washed in blocking buffer (four times, for 15 min each). ATP7B protein was detected with a 1 : 1000 dilution of a horseradish-peroxidase-conjugated goat anti-rabbit antibody and a chemiluminescence detection kit (Boehringer catalogue no. 1500798).
Sectioning
Tissue blocks (0.1 cm$) were immersed in OCT (Tissue Tek) and frozen in liquid nitrogen for 3 min, then sectioned (Leica CM 1800 cryostat) at between k17 mC and k20 mC. Sections 8-10 µm thick were collected on slides coated with gelatin (5 %, w\v).
Staining with haematoxylin and eosin
Tissue sections were air-dried for 20 min, then fixed in 4 % (w\v) paraformaldehyde for 10 min at room temperature [13] and hydrated through an ethanol series [100 %, 70%, 50% and 20 % (v\v)] to deionized water, leaving them for 1 min in each solution. Instant haematoxylin stain was applied to the sections for 5 min, followed by a rinse with deionized water. Sections were immersed in Scott's tap water for 20 s, rinsed in deionized water and differentiated in ethanol containing 1 % (v\v) HCl for 2 s. After the sections had been rinsed with deionized water, yellow eosin stain was applied for 2-3 min and washed off in deionized water ; the sections were then dehydrated in an ethanol series [20 %, 50%, 70% and 100 % (v\v)], leaving them for 1 min in each solution. DPX was added and a coverslip was applied.
Immunohistochemistry
The sections were dried and fixed in paraformaldehyde as described above, rinsed twice for 10 min in PBS, then permeabilized with 5 % (v\v) Triton X-100 in PBS for 5 min and blocked with 3 % (w\v) BSA in PBS for 90 min. ATP7B antibody, diluted 1 : 250 with 1 % (w\v) BSA in PBS, and pre-immune rabbit antiserum, diluted 1 : 1000 with 1 % (w\v) BSA in PBS, were applied to tissues for 2 h at room temperature. After three washes with PBS, the second antibody, dichlorotriazinyl amino fluorescein-conjugated AffiniPure Donkey anti-rabbit IgG (Jackson Immunoresearch Laboratories) or FITC-conjugated sheep anti-mouse IgG (Sigma) [dilution 1 : 200 in 1 % (w\v) BSA in PBS] was applied for 2 h. Sections were washed twice for 10 min in PBS and, where indicated, ethidium bromide (1 µg\ml) was added for 5 min to stain the nuclei lightly. A drop of Fluoroguard (Bio-Rad) was added to the sections and a coverslip was applied. Epifluorescence was viewed with an Olympus BX50 microscope with a PlanApo 60imagnification, 1.4 numerical aperture oil objective. Confocal images were collected with an Optiscan F900e system in a 512i512 pixels format.
RESULTS
Copper concentrations in normal and tx mouse stomach contents and livers
The copper concentration of stomach contents of pups was dependent on the genotype of the lactating dam rather than that of 
Figure 1 Western-blot analysis of mouse breast tissue and liver extracts
Tissue extracts were prepared as described in the Materials and methods section and analysed by SDS/PAGE the pup and was used as an indicator of the copper content of milk. The copper concentration in the stomach contents of 5-day-old normal (DL) pups fostered on normal mothers was 6.4p2.0 µg of copper\g dry weight but in normal pups on tx mothers it was significantly lower (1.2p0.3 µg of copper\g dry weight ; t test P l 1.4i10"#) ( Table 1) . The low copper concentration is consistent with a marked decrease in the delivery of copper to the milk in the tx dam, similar to that in a previous study [4] . The low copper concentration in milk led to a marked decrease in the copper concentration in the livers of pups : only 6.4p0.7 µg of copper\g dry weight in normal pups fostered to tx dams (t test P l 1.9i10 −"$ ) compared with 127 µg of copper\g dry weight in the livers of the normal pups fostered to normal dams (Table 1) .
Copper concentrations in normal and tx mouse stomach contents and livers after dietary supplementation with copper
To determine whether dietary supplementation of lactating dams with copper could influence the copper concentration in milk and copper in the livers of pups, lactating normal and tx dams were provided with copper-loaded drinking water (0.1 mg\ml copper as copper acetate) from the time of mating. The copper concentration in the stomach contents of normal pups fostered on copper-treated normal mothers was 8.0p2.0 µg of copper\g dry weight, which was significantly higher (t test P l 1.4i10 −% ) than the copper concentration of the stomach contents of pups suckling on dams not supplemented with copper (6.4p2.0 µg of copper\g dry weight) ( Table 1) . Surprisingly, the copper concentration in the stomachs of pups on tx mothers receiving copper-supplemented water was lower (0.9p 0.2 µg of copper\g dry weight) than the copper concentration in pups sucking on the dams receiving normal water (1.2p0.3 µg of copper\g dry weight) (t test P l 6i10 −$ ) ( Table 1) .
The copper concentration in livers of normal pups fostered on copper-treated normal mothers was 202p49 µg of copper\g dry weight. This result was significantly higher (P l 5.8i10 −' ) than that of normal pups fostered on normal dams not receiving copper-supplemented water (127p47 µg of copper\g dry weight), supporting the observation that the pups were exposed to higher concentrations of copper in milk when the mother was supplemented with copper. In comparison, the copper concentration in livers of DL pups fostered on copper-treated tx mothers was 6.5p1.6 µg of copper\g dry weight, which was similar to that of the pups fostered on tx mothers not supplemented with copper (6.4p0.7 µg of copper\g dry weight). Thus, even in coppersupplemented tx dams, little copper appeared in the milk.
Copper concentrations in the normal and tx mammary gland
The copper concentration in the mammary glands of lactating tx mice was 7.8 µg\g dry weight, which was not significantly higher than that of normal mice (6.5 µg\g dry weight ; Table 1 ). After dietary copper supplementation, the copper concentration of normal mammary glands did not increase significantly (t test P l 0.03). In contrast, the mammary copper concentration of the tx mice was increased 3-fold to 27 µg\g dry weight after supplementation with copper. This increase, together with the results for copper from stomach contents and from pup livers, suggests that more copper was available to the mammary gland in the copper-supplemented dams and that it was secreted into the milk in normal mice but accumulated in the mammary gland of tx dams.
Western-blot analyses of mouse mammary glands
Western blots of non-lactating mammary-gland extracts incubated with the anti-ATP7B antibody detected bands of size 160 kDa in both the control (DL) and the tx mouse tissue ( Figure 1A) . A band of size 160 kDa was also found in a sample of DL liver, which was used as a control. Similar levels of ATP7B protein were found in the control mammary gland, the tx mouse mammary gland and the control liver, suggesting that the mammary gland is a major site of expression of ATP7B. The lactating tissue extracts also showed bands of 160 kDa in both the DL mouse and the tx mouse ( Figure 1B) . Comparable levels of ATP7B protein were found in the DL lactating mammary gland and liver and in the tx mouse lactating mammary gland. The levels of ATP7B protein were similar in the lactating and the non-lactating gland ; supplementation of the lactating dams with copper did not affect the expression of ATP7B in either DL or tx mammary glands ( Figure 1C) .
Immunolocalization of ATP7B in mammary glands
A section through non-lactating tx tissue stained with haematoxylin and eosin (Figure 2A) shows a duct, distinguished by its irregular shape and several alveoli, all of which are lined with an inner layer of luminal epithelial cells and an outer layer of myoepithelial cells. In lactating tx tisssue ( Figure 2B ), numerous alveoli containing secretory material can be seen. No structural differences between DL and tx mammary glands were seen after a microscopic examination of sections of non-lactating or lactating tissue stained with haematoxylin and eosin.
In non-lactating mice, ATP7B was present in the luminal epithelial cells of the mammary gland as a granular perinuclear label ; there was no obvious difference in ATP7B distribution between the DL gland ( Figure 2C ) and the tx gland ( Figure 2D ).
In the lactating DL mouse mammary gland, ATP7B protein was detected as a diffuse, granular, cytoplasmic label ( Figure  3A) . In contrast, ATP7B protein in the lactating tx mouse mammary gland was localized to the perinuclear region ; only a minor proportion of the fluorescence was detected in the cytoplasm ( Figure 3B ).
Effect of dietary copper loading on the subcellular distribution of ATP7B protein in the lactating mammary gland
To determine whether the perinuclear distribution of ATP7B in the mammary epithelial cells of tx mice could be influenced by dietary copper treatment, lactating DL and tx mice were provided with water containing 0.1 mg\ml copper as copper acetate for up to 3-4 months before the birth of the pups. Treatment of lactating DL mice with copper did not affect the subcellular distribution of ATP7B compared with lactating dams not treated with copper. In the copper-treated lactating DL mice, ATP7B was detected as a granular cytoplasmic label ( Figure 3C ) and this distribution of ATP7B was similar to that seen in the lactating DL mice not treated with copper ( Figure 3A) . In contrast, after treatment of the lactating tx mouse with copper, ATP7B was detected as a granular label localized to a region of the cytoplasm between the nucleus and the cell membrane ( Figure 3D ).
DISCUSSION
Our results unequivocally confirm that there is impaired transport of copper into milk in lactating tx mice and establish that ATP7B is the major copper transporter in the mammary gland, delivering copper into breast milk. The origin of copper deficiency in tx milk is the result of a failure of copper to be secreted into milk rather than of a failure of copper to be delivered to the mammary gland as a secondary consequence of defective ATP7B in the liver. Furthermore, long-term dietary copper supplementation did not overcome the copper deficiency in toxic milk. Our results suggest that the copper transport defect in the tx mouse involves defective trafficking of the ATP7B protein in the tx mammary gland during lactation.
The localization of ATP7B was found to undergo a marked change in response to lactation in the normal mouse. In the nonlactating gland, the protein was in a perinuclear region consistent with localization to the trans-Golgi network, as has been reported for ATP7B in cultured cells [8, 10] . However, in the lactating gland the distribution of ATP7B was diffuse and resembled that seen in cells exposed to an elevated concentration of copper [8, 9] . This observation shows that the trafficking of ATP7B seen in cultured cells is not simply a non-physiological artefact but is observed under physiological conditions and is presumably important in the secretion of copper into milk.
The most significant finding of our study was that the ATP7B protein in the tx mouse mammary gland did not disperse in response to lactation but remained in the perinuclear region of the cell. In other studies, mutant ATP7B molecules show defective trafficking in response to copper ; for example, ATP7B with the common disease-causing H1069Q mutation remained in the trans-Golgi network even when cells were exposed to an elevated concentration of copper [10] . Results from our laboratory with Chinese hamster ovary cells transiently transfected with the tx construct show that copper-induced trafficking of ATP7B protein is abolished (M. Theophilos and J. F. B. Mercer, unpublished work). The link between mutations that prevent copper transport (such as that expected for the tx mutation, which is in the eighth transmembrane domain) and blocking trafficking is not clear but it is also found for mutations in the Menkes protein, ATP7A [11] . Whatever the mechanism, the defective trafficking contributes to the failure of the copper efflux mechanism in the gland.
Treatment of the lactating DL mouse with copper did not cause any change in the localization of ATP7B protein compared with lactating mice not treated with copper. It was somewhat unexpected to find that treatment of the lactating tx mouse with copper caused a redistribution of the ATP7B protein to a more peripheral region of the cell, between the cytoplasm and the nucleus. However, the distribution was not as extensive as that seen in the normal lactating gland and this result suggests that, in the mammary gland, the mutant ATP7B protein seems to have retained some capacity for trafficking. The difference in trafficking between the systems in itro and in i o might be related to the fact that the more complex system in i o in the mammary gland consists of interacting polarized cells, compared with the nonpolarized, transformed lines used in the cell-culture studies. This observation merits further investigation.
It is interesting that the levels of ATP7B protein in the mammary gland were as high as those found in the liver, which suggests that the role of ATP7B in copper efflux is as important in the mammary gland as in the liver, the main organ of wholebody homoeostasis. Our results showed that the expression levels of ATP7B protein were not increased in lactating tissue relative to non-lactating tissue. Thus the relocalization of the ATP7B protein to a peripheral cytoplasmic compartment might be a key factor in providing an increased delivery of copper to the milk during lactation.
Our results showed that the copper concentrations in the tx mammary gland were not significantly higher than those of the normal mammary gland. This contrasts with the doubling of mammary copper levels in three lactating ATP7B knock-out mice relative to that of three control mice [7] . The difference between the two could be related to the severity of the mutation. We have shown that the tx mouse does produce ATP7B protein but, in comparison with the null mutation, the mis-sense mutation in transmembrane 8 of the tx mouse might allow some residual copper-transporting activity and maintain lower copper concentrations than the complete knock-out of ATP7B.
To determine whether the delivery of copper in the milk of tx mice could be restored by dietary copper supplementation, copper-loaded (0.1 mg\ml) water was provided to lactating normal and tx mice. This resulted in a 33 % increase in the copper concentrations in the stomachs of pups reared by normal mice and a near doubling of the hepatic copper concentration in the livers of the pups, indicating that more copper was secreted into milk and was absorbed by the pups. Thus copper concentrations in milk are increased if the maternal diet contains large amounts of copper ; however, the increase is relatively minor compared with the large amounts of copper being consumed by the animals. In contrast, the treatment of tx dams with copper did not increase the delivery of copper to milk ; neither were the copper concentrations in livers of pups reared by tx dams increased. Interestingly, the concentration of copper in the mammary gland of the copper-loaded tx mouse was increased approx. 3-fold with copper loading. This result supports our conclusion that the production of copper-deficient milk is not due to a lack of copper reaching the mammary gland but is due to a defect in the capacity of the tx mammary gland to transfer copper into milk.
Our results suggest that ATP7B protein has an important function in transporting copper into milk in the mammary gland. However, the observation that even when this protein is defective there is still some copper present in milk (approximately onesixth the normal level) suggests the presence of another pathway for the secretion of copper. There are several possible additional pathways : one involves the copper protein ceruloplasmin, which is synthesized in the mammary gland and secreted into milk [14] and might account for 25 % of the copper in milk [15] . However, this source of copper would also be expected to be decreased in the tx mouse, because ATP7B is most probably involved in the delivery of copper to ceruloplasmin in the mammary gland as well as in the liver. The role of ATP7A, the Menkes copper ATPase, in mammary-gland copper homoeostasis is still unclear.
In previous studies we showed that the levels of expression of ATP7A mRNA and ATP7B mRNA in human breast epithelial cells were similar [16] and that there was an increased expression of the Menkes gene in the lactating human mammary gland [17] . It is possible that the residual copper in the tx mouse is delivered by means of the Menkes protein. There might be other pathways for the delivery of copper to milk not involving the Cu-ATPases but our results suggest strongly that the primary delivery system is the ATP7B protein.
In conclusion, we have demonstrated that a defective localization of the ATP7B protein is responsible for the low concentration of copper in the milk of the toxic-milk mouse. Our findings suggest that ATP7B is trafficked in the mammary gland in response to physiological stimuli and is directly involved in copper homeostasis in the newborn mouse. Dietary copper supplementation was ineffective in increasing the copper content of milk from the tx mouse, implying that normal homoeostatic mechanisms for copper transport in the mammary gland are defective.
We thank Sophie Gazeas for assistance with the mice.
